Melanie Cerullo is responsible for Arranta’s Quality and Regulatory functions, including Quality Assurance and Quality Control. Ms. Cerullo has more than 23 years of experience in QA and QC in GMP manufacturing operations. She was formerly the Vice President of CMC and Quality at Wave Life Sciences, where she built the Quality organization to support early phase internal manufacture and quality oversight of CDMOs, managed the Analytical Development and Drug Product Formulation teams, and established the CMC product development program for Wave’s clinical portfolio. Ms. Cerullo holds a BS in chemistry from Rhode Island College and a MS in quality assurance and regulatory affairs from Temple University.
.svg)
